Evidence map›Paper›PMID 42256392›Full record

ArticleFrontiers in pharmacology2026

Factors associated with non-adherence to antihypertensive therapy and blood pressure control in Iraq.

Mohamed AbdElrahman, Ghadah Ali Al-Oudahl, Hasanain Kamil Owadh, Asmaa Saleh, Gufran Kareem Hassan, Sara Adnan Mohsen, Um Albanen Haider, Aya Amer Abd-Alredah, Manar Ahmed Hussein, Mohammed Liqaa Abdul-Abbas and 3 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mohamed AbdElrahmanClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Ghadah Ali Al-OudahlClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Hasanain Kamil OwadhClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Asmaa SalehDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Gufran Kareem HassanClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Sara Adnan MohsenClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Um Albanen HaiderClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Aya Amer Abd-AlredahClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Manar Ahmed HusseinClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Mohammed Liqaa Abdul-AbbasClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Abduallah Mohammed MojedClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Abdullatif Saad ObaidClinical Pharmacy Department, College of Pharmacy, Al-Mustaqbal University, Babylon, Iraq.
Amira B KassemDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Objectives: Hypertension is a major global public health concern, affecting approximately 1.28 billion people worldwide, with a disproportionate burden in low- and middle-income countries. Poor adherence to antihypertensive therapy is widely recognized as a key factor associated with inadequate blood pressure control and increased cardiovascular risk. Understanding the factors associated with non-adherence among hypertensive patients is essential for informing context-specific strategies to improve medication-taking behavior and clinical outcomes. Methods: A cross-sectional study was conducted among 585 hypertensive patients in Iraq. Sociodemographic, medication-related, economic, and self-care characteristics were collected using standardized questionnaires. Medication adherence was assessed through patient self-report. Factors associated with non-adherence were examined using multivariable logistic regression, with results reported as adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Results: Non-adherence was more prevalent among younger patients (18-30 years, 33.3%) compared with older patients (>60 years, 1.9%) (p < 0.001). Increasing age was associated with lower odds of non-adherence (adjusted OR 0.37, 95% CI: 0.24-0.56, p < 0.001). Student status was associated with higher odds of non-adherence (OR 2.43, 95% CI: 1.36-4.35, p = 0.002). Regular home blood pressure monitoring was associated with reduced odds of non-adherence (OR 0.54, 95% CI: 0.29-0.98, p = 0.047). Gender, place of residence, financial barriers, and provider communication were not significantly associated with adherence. Conclusion: In this Iraqi cohort, non-adherence to antihypertensive therapy was associated with younger age, student status, and limited self-care practices. These findings help identify subgroups that may benefit from consideration in the design and evaluation of patient-centered support strategies, including adherence-focused education, structured follow-up, and promotion of home blood pressure monitoring. Given the cross-sectional nature of the study, causal relationships cannot be inferred, and future longitudinal and interventional research is warranted to determine the effectiveness of such approaches in improving medication adherence and blood pressure management in resource-constrained settings.

Indexed as

antihypertensive pharmacotherapycardiovascular pharmacologyIraqmedication adherencerational drug use

Identifiers

PMID42256392
PMCPMC13234455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.